The rise in medication usage for weight loss unlocks opportunities for innovation in health-focused products and ...

- Dan Monahan will lead the commercialization strategy across Amylyx’ product portfolio, beginning with avexitide, an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor ...

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...

About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income ...

The "Semaglutides Market Report 2024" report has been added to ResearchAndMarkets.com's offering. This Semaglutides market report covers market characteristics, size and growth, segmentation, regional ...

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

Researchers have found that polyphenols cause the secretion of hormones that may help lower a risk of developing type 2 ...

Semaglutide biosimilar is under clinical development by Leto Laboratories and currently in Phase II for Diabetes.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

More than two billion people worldwide live with overweight or obesity, conditions closely linked to an array of health ...

Claiming Science magazine's breakthrough of the year in 2023 , these drugs are an absolute revelation: they give you ...

Discover the inspiring weight loss journey of a dietitian who overcame PCOS and pregnancy challenges to achieve lasting ...